Results 181 to 190 of about 25,713 (274)

Intrarenal production of B cell survival factors in human lupus nephritis [PDF]

open access: yes, 2011
Cohen, C D   +7 more
core   +1 more source

Real‐World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry

open access: yesUnited European Gastroenterology Journal, Volume 14, Issue 4, May 2026.
ABSTRACT Background Upadacitinib (UPA) is the first oral Janus kinase (JAK) inhibitor approved for the treatment of Crohn's disease (CD). Real‐world data, particularly from large nationwide cohorts, remain limited. This study aimed to evaluate the real‐world effectiveness, safety, and treatment persistence of UPA in patients with CD.
M. Iborra   +51 more
wiley   +1 more source

Death anxiety predicts fear of progression in people with rheumatic conditions

open access: yesBritish Journal of Health Psychology, Volume 31, Issue 2, May 2026.
Abstract Background Rheumatic diseases often have a progressive course and place individuals at increased risk of mortality. Despite this, little research has investigated the relationship between death anxiety and fears about disease progression (FoP), and how these might relate to health‐related quality of life (HRQoL) outcomes.
Bethany Richmond   +4 more
wiley   +1 more source

Elevated IL-8 and abnormal lymphocytes in pediatric primary Sjögren's syndrome: a single-center study. [PDF]

open access: yesEur J Med Res
Gao XF   +11 more
europepmc   +1 more source

Animal Models of Hunner‐Type Interstitial Cystitis

open access: yesInternational Journal of Urology, Volume 33, Issue 5, May 2026.
ABSTRACT Background Animal models are crucial for mechanistic studies and therapeutic development of human diseases. At present, the etiology of interstitial cystitis/bladder pain syndrome (IC/BPS), a chronic disease of the urinary bladder, remains undefined.
Yoshiyuki Akiyama, Yi Luo
wiley   +1 more source

Effectiveness of low-dose doxycycline (LDD) on clinical symptoms of Sjögren's Syndrome: a randomized, double-blind, placebo controlled cross-over study [PDF]

open access: yes
Hubertus Seitsalo   +33 more
core   +1 more source

Home - About - Disclaimer - Privacy